NasdaqGS:SGRYHealthcare
Stronger Q1 Results And Reaffirmed Outlook Might Change The Case For Investing In Surgery Partners (SGRY)
Surgery Partners, Inc. recently reported first-quarter 2026 results, with revenue rising to US$810.9 million from US$776.0 million a year earlier and net loss narrowing to US$35.9 million, while reaffirming full-year 2026 revenue guidance of US$3.35 billion to US$3.45 billion.
Beneath the headline loss, the company delivered a smaller-than-expected adjusted loss per share and 4.4% same-facility revenue growth, highlighting underlying volume and pricing momentum despite higher costs and a...